Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virus

Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virus

US Patent 10421978 · Granted Sep 24, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Virus-based expression vectors and uses thereof2021
Virus-based expression vectors and uses thereof2021
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructure2018
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructure2018
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructure2018
Monoclonal antibodies against orthopoxviruses2017
Monoclonal antibodies against orthopoxviruses2017
Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV 2016
Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV 2016
Compositions and methods for generating an immune response2016
Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding2015
Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding2015